Managing supply chain disruption in the life sciences and health care industry: Part 1 – Supply chain risk management and immediate actions

The COVID-19 outbreak has produced an instant global economic shock that is – inevitably – affecting global supply chains.

It is the ultimate stress test for international businesses, with yet unclear economic consequences. As such, COVID-19 triggers a whole number of questions: How do I manage the risk for my supply chain? Is my supply chain sufficiently resilient? What are the "lessons learned," and how can I improve my responses to high impact scenarios like COVID-19?

We are hosting a series of two webinars in panel discussion format in which our global and cross-practice team of life sciences experts will give you helpful tips on how to prevent, react, and respond to supply chain disruptions focusing on the specific issues related to the life sciences and health care industry.

We considered in this first event the potential impact of COVID-19 on supply chain in the life sciences sector; we broadened the discussion and discussed what you have to do if you see the risk of a supply chain disruption and finally what to do in case one is happening.

Part 1 – Supply chain risk management and immediate actions

  • Potential impact of COVID-19 on supply chains in the life sciences sector.
  • What do I have to do if I see the risk of a supply chain disruption? – Supply chain risk management and risk mitigation, specifically:
    • Contracts.
    • Regulatory.
    • Legal & business consideration.
    • Competition law.
    • Creative alternative dispute resolution solutions.
  • What do I have to do in case of a supply chain disruption?


Back To Listing
Loading data